Pierzynowska Kateryna, Pierzynowski Stefan, Zaworski Kamil, Gallotto Robert, Sathe Meghana, Freedman Steven D, Borowitz Drucy
Department of Biology, Lund University, Lund, Sweden.
Department of Animal Physiology, The Kielanowski Institute of Animal Physiology and Nutrition, Polish Academy of Sciences, Jabłonna, Poland.
PLoS One. 2025 May 19;20(5):e0323730. doi: 10.1371/journal.pone.0323730. eCollection 2025.
Current methods to measure the effectiveness of pancreatic protease activity are inadequate. We explored the measurement of peptide-derived amino acids following ingestion of dietary whey substrate as a sensitive test of exogenous protease activity in exocrine pancreatic insufficient (EPI) pigs.
We studied the activity of aspergillus protease given in combination with a novel lipase and fungal amylase, as well as commercially available pancrelipase in EPI pigs. After a high-fat diet plus a standardized dietary whey substrate, blood was withdrawn at intervals and was analyzed for amine groups using a modified ninhydrin reaction. Plasma peptide-derived amino acids were calculated.
The AUC6 peptide-derived amino acid concentration was significantly increased in response to aspergillus protease as follows: 50 mg dose (137% increase; p = 0.05), 75 mg dose (154% increase; p = 0.008) compared to no enzyme. The AUC6 for peptide-derived amino acids after aspergillus protease increased by 133% for the 50 mg dose (p = 0.0044), by 171% for the 75 mg dose (p = 0.0002), and by 113% with 600 mg pancrelipase (p < 0.0001) when compared to no enzyme. Administration of 75 mg of aspergillus protease led to significantly higher peptide-derived amino acid AUC6 and Cmax when compared to 600 mg pancrelipase (p = 0.0419 and 0.0103, respectively).
In EPI pigs, measurement of peptide-derived amino acids following a meal with whey substrate differentiates the activity of aspergillus protease compared to no enzyme and the 75 mg dose was superior to pancrelipase. The evidence presented here in EPI pigs demonstrates that the whey substrate absorption challenge test reflects the proteolytic activity of different doses of exogenous pancreatic proteases.
目前用于测量胰腺蛋白酶活性有效性的方法并不完善。我们探索了在摄入膳食乳清底物后测量肽衍生氨基酸,以此作为外分泌性胰腺功能不全(EPI)猪中外源蛋白酶活性的敏感测试。
我们研究了将曲霉蛋白酶与一种新型脂肪酶和真菌淀粉酶联合使用的活性,以及在EPI猪中使用市售胰酶。在高脂饮食加标准化膳食乳清底物后,定期采血并使用改良茚三酮反应分析胺基。计算血浆肽衍生氨基酸。
与不使用酶相比,曲霉蛋白酶作用下肽衍生氨基酸浓度的AUC6显著增加,如下所示:50mg剂量(增加137%;p = 0.05),75mg剂量(增加154%;p = 0.008)。与不使用酶相比,曲霉蛋白酶作用后肽衍生氨基酸的AUC6在50mg剂量时增加了133%(p = 0.0044),在75mg剂量时增加了171%(p = 0.0002),在使用600mg胰酶时增加了113%(p < 0.0001)。与600mg胰酶相比,给予75mg曲霉蛋白酶导致肽衍生氨基酸AUC6和Cmax显著更高(分别为p = 0.0419和0.0103)。
在EPI猪中,餐后用乳清底物测量肽衍生氨基酸可区分曲霉蛋白酶与不使用酶时的活性,且75mg剂量优于胰酶。在EPI猪中呈现的证据表明,乳清底物吸收激发试验反映了不同剂量外源性胰腺蛋白酶的蛋白水解活性。